COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 160 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $285 | +4.8% | 12,765 | +0.8% | 0.00% | – |
Q2 2023 | $272 | -33.7% | 12,659 | -25.9% | 0.00% | -100.0% |
Q1 2023 | $410 | -30.2% | 17,087 | -32.4% | 0.00% | 0.0% |
Q4 2022 | $587 | -99.9% | 25,286 | -55.0% | 0.00% | 0.0% |
Q3 2022 | $900,000 | -16.7% | 56,176 | -7.9% | 0.00% | 0.0% |
Q2 2022 | $1,080,000 | -3.4% | 60,971 | +11.1% | 0.00% | 0.0% |
Q1 2022 | $1,118,000 | +160.0% | 54,892 | +138.7% | 0.00% | – |
Q4 2021 | $430,000 | -21.8% | 22,994 | -17.5% | 0.00% | -100.0% |
Q3 2021 | $550,000 | -27.9% | 27,865 | -13.7% | 0.00% | 0.0% |
Q2 2021 | $763,000 | +0.7% | 32,294 | +0.9% | 0.00% | 0.0% |
Q1 2021 | $758,000 | +18.3% | 32,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $641,000 | -3.8% | 32,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $666,000 | +18.9% | 32,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $560,000 | +7.1% | 32,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $523,000 | -20.6% | 32,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $659,000 | +63.9% | 32,000 | -8.6% | 0.00% | 0.0% |
Q3 2019 | $402,000 | -12.6% | 35,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $460,000 | +10.8% | 35,000 | +27.7% | 0.00% | 0.0% |
Q1 2019 | $415,000 | -11.7% | 27,400 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $470,000 | -2.5% | 27,400 | -16.2% | 0.00% | 0.0% |
Q3 2018 | $482,000 | -57.8% | 32,700 | -31.6% | 0.00% | 0.0% |
Q2 2018 | $1,141,000 | +2.6% | 47,833 | +9.9% | 0.00% | 0.0% |
Q1 2018 | $1,112,000 | +53.2% | 43,533 | +10.7% | 0.00% | 0.0% |
Q4 2017 | $726,000 | +185.8% | 39,333 | +62.5% | 0.00% | – |
Q3 2017 | $254,000 | -16.2% | 24,200 | 0.0% | 0.00% | – |
Q2 2017 | $303,000 | +91.8% | 24,200 | +54.1% | 0.00% | – |
Q1 2017 | $158,000 | -26.5% | 15,701 | +13.8% | 0.00% | – |
Q4 2016 | $215,000 | -19.2% | 13,800 | 0.0% | 0.00% | – |
Q3 2016 | $266,000 | +62.2% | 13,800 | 0.0% | 0.00% | – |
Q2 2016 | $164,000 | -0.6% | 13,800 | +51.5% | 0.00% | – |
Q1 2016 | $165,000 | -1.8% | 9,108 | +49.3% | 0.00% | – |
Q4 2015 | $168,000 | +24.4% | 6,100 | 0.0% | 0.00% | – |
Q3 2015 | $135,000 | +84.9% | 6,100 | +49.7% | 0.00% | – |
Q2 2015 | $73,000 | – | 4,076 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |